PinnyPeptide

Cartalax vs Testagen

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Cartalax

Bioregulators

Khavinson short peptide bioregulator targeting chondrocytes and connective tissue.

Peptide B

Testagen

Bioregulators

Khavinson short peptide bioregulator targeting testicular tissue.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Cartalax effects

  • Reported support of chondrocyte function and cartilage matrix synthesis
  • Improvements in joint pain and mobility (Russian observational)
  • Possible slowing of age-related cartilage degradation
  • Recovery support after cartilage injury
  • Modulation of connective-tissue gene expression

Testagen effects

  • Reported support of Leydig cell testosterone production
  • Possible improvement in sperm parameters
  • Support of overall reproductive function
  • Anti-inflammatory effects in testicular tissue
  • Modulation of testicular gene expression

Cartalax side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation

Testagen side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Should not substitute for proper hypogonadism evaluation

Cartalax dosing ranges

Joint / cartilage support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Testagen dosing ranges

Reproductive support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Full Cartalax guide → Full Testagen guide →

Cartalax vs Testagen — common questions

What is the difference between Cartalax and Testagen?

Cartalax: Khavinson short peptide bioregulator targeting chondrocytes and connective tissue. Typical dose 1,000-5,000 mcg. Testagen: Khavinson short peptide bioregulator targeting testicular tissue. Typical dose 1,000-5,000 mcg. Both fall under the Bioregulators category.

Can you stack Cartalax and Testagen?

Stacking Cartalax with Testagen is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Cartalax or Testagen?

Cartalax is typically dosed: Once daily (SubQ) or sublingual for Joint / cartilage support. Testagen is typically dosed: Once daily (SubQ) or sublingual for Reproductive support.

Are Cartalax and Testagen FDA approved?

Cartalax: Not FDA approved. Testagen: Not FDA approved.

Related peptide comparisons

bronchogen vs cartalaxcardiogen vs cartalaxcartalax vs cortagencartalax vs crystagencartalax vs ovagencartalax vs pancragen

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free